The Exciting Potential of Electric Field Stimulatio?n

Cellectricon, a leading provider of advanced cell-based screening technologies and services, will be presenting new data at Neuroscience 9–13 November 2013, San Diego (USA).

In a series of poster presentations, Cellectricon (booth #933) will demonstrate how its technology can be applied effectively for drug discovery, particularly in relation to cytoskeletal disorders and neurodegenerative diseases. Cellectricon’s novel approach is based around electric field stimulation, and the posters, which include primary data, detail how the Cellaxess technology can be used to deliver pharmacologically active molecules to neuronal cultures without compromising cell viability or functionality.

The poster session will also reveal an assay for the high-throughput identification of compounds that modulate neuronal excitability. In this way, attendees will be shown how compound characterisation and data-based decision making can be achieved early in a project life-cycle, reducing unnecessary time and cost.

The poster presentations take place on 11–13 November, and Cellectricon employees will be on-hand to answer any questions you may have during this time.

Small Molecule Delivery into primary neuronal cells capillary-electrode Electroporation  Monday 11 Nov, 10–11am

A method for patch-clamp recordings of fast-acting ion channels in rat dorsal root ganglion cells  Tuesday 12 Nov, 11–12am

Characterization of the subpopulation of neurons responding in an electric field stimulation assay   Wednesday 13 Nov, 2–3pm

Development of a high throughput electric field stimulation assay for identification of compounds modulating excitability in sensory neurons Wednesday 13 Nov, 4-5pm